Deutsche Bank
ARCT icon

Deutsche Bank’s Arcturus Therapeutics ARCT Stock Holding History

Deutsche Bank’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195K Sell
28,994
-2,370
-8% -$18.7K ﹤0.01% 3270
2026
Q1 		$242K Buy
31,364
+12,991
+71% +$94.8K ﹤0.01% 2925
2025
Q4 		$113K Buy
18,373
+946
+5% +$10.2K ﹤0.01% 3257
2025
Q3 		$321K Buy
17,427
+2,932
+20% +$47.1K ﹤0.01% 2803
2025
Q2 		$189K Sell
14,495
-12,785
-47% -$151K ﹤0.01% 3000
2025
Q1 		$289K Buy
27,280
+2,512
+10% +$39.9K ﹤0.01% 2772
2024
Q4 		$420K Buy
24,768
+7,417
+43% +$140K ﹤0.01% 2702
2024
Q3 		$403K Sell
17,351
-12,319
-42% -$264K ﹤0.01% 2587
2024
Q2 		$722K Sell
29,670
-1,276
-4% -$38.7K ﹤0.01% 2153
2024
Q1 		$1.05M Buy
30,946
+773
+3% +$27.4K ﹤0.01% 2000
2023
Q4 		$951K Sell
30,173
-253
-0.8% -$6.01K ﹤0.01% 2053
2023
Q3 		$777K Sell
30,426
-7,160
-19% -$221K ﹤0.01% 1888
2023
Q2 		$1.08M Sell
37,586
-6,484
-15% -$177K ﹤0.01% 1947
2023
Q1 		$1.06M Buy
44,070
+4,189
+11% +$75.2K ﹤0.01% 2067
2022
Q4 		$676K Buy
39,881
+29,300
+277% +$511K ﹤0.01% 2279
2022
Q3 		$157K Sell
10,581
-2,832
-21% -$47.5K ﹤0.01% 3081
2022
Q2 		$210K Sell
13,413
-10,535
-44% -$207K ﹤0.01% 3127
2022
Q1 		$645K Buy
23,948
+261
+1% +$6.66K ﹤0.01% 2598
2021
Q4 		$877K Buy
23,687
+3,071
+15% +$125K ﹤0.01% 2521
2021
Q3 		$985K Sell
20,616
-185
-0.9% -$8.29K ﹤0.01% 2622
2021
Q2 		$704K Buy
20,801
+1,372
+7% +$46.4K ﹤0.01% 3006
2021
Q1 		$803K Buy
19,429
+1,117
+6% +$66.6K ﹤0.01% 2811
2020
Q4 		$794K Buy
18,312
+8,115
+80% +$550K ﹤0.01% 2605
2020
Q3 		$438K Sell
10,197
-511,470
-98% -$25.4M ﹤0.01% 2727
2020
Q2 		$24.4M Buy
+521,667
New +$18M 0.02% 642
2020
Q1 		– Sell
-4,204
Closed -$45K – 4314
2019
Q4 		$45K Buy
4,204
+4,156
+8,658% +$43.5K ﹤0.01% 4014
2019
Q3 		$0 Buy
+48
New +$519 ﹤0.01% 4864
2018
Q1 		– Sell
-100
Closed – – 5377
2017
Q4 		$0 Buy
+100
New +$899 ﹤0.01% 4982
2017
Q1 		– Sell
-4,741
Closed -$69K – 4892
2016
Q4 		$69K Sell
4,741
-955
-17% -$14.3K ﹤0.01% 4238
2016
Q3 		$97K Sell
5,696
-560
-9% -$18.1K ﹤0.01% 3951
2016
Q2 		$195K Sell
6,256
-7,541
-55% -$238K ﹤0.01% 3786
2016
Q1 		$365K Sell
13,797
-2,649
-16% -$89.7K ﹤0.01% 3376
2015
Q4 		$722K Buy
16,446
+7,236
+79% +$326K ﹤0.01% 3085
2015
Q3 		$389K Sell
9,210
-186
-2% -$9.78K ﹤0.01% 3499
2015
Q2 		$430K Buy
+9,396
New +$431K ﹤0.01% 3482
2014
Q1 		– Sell
-286
Closed -$36K – 5588
2013
Q4 		$36K Buy
+286
New +$35.9K ﹤0.01% 4488

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Deutsche Bank's ARCT Position: Q2 2026 in Review

Deutsche Bank reduced its Arcturus Therapeutics (ARCT) stake by 7.6% in Q2 2026, selling an estimated $18.7K and leaving 28,994 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #3270.

Deutsche Bank first reported a position in ARCT in Q4 2013 and has held it in 36 quarters since. The position peaked at $24.4M in Q2 2020. 136 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Deutsche Bank held 28,994 shares of Arcturus Therapeutics worth $195K as of Q2 2026.
  • Deutsche Bank sold 2,370 Arcturus Therapeutics shares in Q2 2026, an estimated $18.7K.
  • Arcturus Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3270 holding.
  • Deutsche Bank first reported a position in Arcturus Therapeutics in Q4 2013 and has held it in 36 quarters since.
  • Deutsche Bank's Arcturus Therapeutics position peaked at $24.4M in Q2 2020.
  • 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.